However, the changes in serum ATG4B and VPS37A levels were consistent with those seen in renal tissues, which partially validates the decrease in autophagy during DKD progression and suggests these two proteins could be used as blood biomarkers to evaluate DKD progression. This evidence concerns the gene ATG4B and diabetic kidney disease.